Home > Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Book Informaton
Author
J. Morganroth; E. Neil Moore
Series
Developments in Cardiovascular Medicine
Volume
100
Year of Publication
1989
Publisher
Springer US
City of Publication
Boston
Pages
XVIII, 298
Language
EN
ISBN
9780792302940, 9781461316053, 079230294X
ARI Id
1664401998275
This page has been accessed 5 times.
Access Options
Citation Options
Download CitationShowing 1 to 20 of 27 entries
Chapters/Headings | Author(s) | Pages | Info |
i-xvi | |||
1-1 | |||
3-13 | |||
15-22 | |||
23-28 | |||
29-46 | |||
47-58 | |||
59-89 | |||
91-91 | |||
93-98 | |||
99-108 | |||
109-116 | |||
117-142 | |||
143-143 | |||
145-151 | |||
153-156 | |||
157-166 | |||
167-198 | |||
199-199 | |||
201-214 | |||
Chapters/Headings | Author(s) | Pages | Info |
Showing 1 to 20 of 27 entries